IP Library Granted Patent US 8,034,934
Granted Patent B2
US 8,034,934 · App. 11/991,529 · Granted Oct 11, 2011

Process for producing ortho-metalated complex of iridium with homoligand

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,934
App. No.
11/991,529
Granted
Oct 11, 2011
Kind
B2
Abstract

Disclosed is a process for producing an ortho-metalated 1:3 complex of iridium with homoligands which is useful as a luminous material for an organic EL device in high yield at high purity in a short time by a simple procedure. An example of the complex is tris(2-phenylpyridine)iridium(III) and this complex can be produced by reacting iridium(III) acetylacetonate with an organic ligand consisting of 2-phenylpyridine in the copresence of an acidic substance, either an organic acid such as tartaric acid or an inorganic acid such as phosphoric acid.

Claims (14)

1. A process for producing an ortho-metalated iridium complex comprising the reaction of iridium(III) acetylacetonate with an organic ligand to produce an ortho-metalated complex of iridium with homoligands wherein the said reaction is carried out in the copresence of an acidic substance selected from Bronsted acids.

2. A process for producing an ortho-metalated iridium complex as described in claim 1 wherein the ortho-metalated complex of iridium with homoligands is a compound represented by the following general formula (1);

in the formula, ring A denotes a 5- or 6-membered aromatic or aromatic hetero ring, either unsubstituted or substituted, ring B denotes a nitrogen-containing 5- or 6-membered hetero ring, either unsubstituted or substituted, any adjacent substituents on ring A or ring B may join together to form a condensed ring, L denotes a single bond or a divalent group, and L, ring A, ring B, and any substituents thereon may join together to form a condensed ring involving ring A and ring B.

3. A process for producing an ortho-metalated iridium complex as described in claim 2 wherein ring B in general formula (1) is the ring of pyridine, pyrimidine, pyrazine, pyridazine, pyrrole, quinoline, isoquinoline, imidazole, pyrazole, thiazole, oxazole, oxadiazole, thiadiazole, 1,2,3-triazole, 1,2,4-triazole, benzothiazole, benzoxazole, or benzimidazole, either unsubstituted or substituted.

4. A process for producing an ortho-metalated iridium complex as described in claim 2 or 3 wherein ring A in general formula (1) is the ring of imidazole, thiazole, oxazole, pyrrole, oxadiazole, thiadiazole, pyrazole, 1,2,3-triazole, 1,2,4-triazole, selenazole, furan, thiophene, benzene, naphthalene, phenanthrene, pyridine, pyrimidine, pyrazine or pyridazine, either unsubstituted or substituted.

5. A process for producing an ortho-metalated iridium complex as described in claim 1 wherein the acidic substance is a Bronsted acid selected from organic acids and inorganic acids.

6. A process for producing an ortho-metalated iridium complex as described in claim 1 wherein the ortho-metalated iridium complex is an ortho-metalated 1:3 complex of iridium and homoligands.

7. A process for producing an ortho-metalated iridium complex as described in claim 1 wherein the reaction in the copresence of the acidic substance is carried out at a temperature in the range of 150 to 220° C.

8. A process for producing an ortho-metalated iridium complex as described in claim 1 wherein at least one kind of compound selected from polyhydric alcohols, esters of polyhydric alcohols, ethers of polyhydric alcohols, and aliphatic hydrocarbons is used as a solvent in the reaction.

9. A process for producing an ortho-metalated iridium complex as described in claim 1 wherein the reaction is carried out at a temperature in the range of 150 to 220° C. in the copresence of the acidic substance selected from Bronsted acids in such a manner as to control the molar ratio of the acidic substance to iridium(III) acetylacetonate in the range of 0.5 to 20.

10. A process for producing an ortho-metalated iridium complex as described in claim 1 wherein the ortho-metalated complex of iridium with homoligands is a compound represented by the following general formula (1);

in the formula, ring A denotes an unsubstituted 5- or 6-membered aromatic or aromatic hetero ring, ring B denotes an unsubstituted nitrogen-containing 5- or 6-membered hetero ring, and L denotes a single bond or a divalent group.

11. A process for producing an ortho-metalated iridium complex as described in claim 2 wherein ring B in general formula (1) is an unsubstituted ring of pyridine, pyrimidine, pyrazine, pyridazine, pyrrole, quinoline, isoquinoline, imidazole, pyrazole, thiazole, oxazole, oxadiazole, thiadiazole, 1,2,3-triazole, 1,2,4-triazole, benzothiazole, benzoxazole, or benzimidazole.

12. A process for producing an ortho-metalated iridium complex as described in claim 2 or 3 wherein ring A in general formula (1) is an unsubstituted ring of imidazole, thiazole, oxazole, pyrrole, oxadiazole, thiadiazole, pyrazole, 1,2,3-triazole, 1,2,4-triazole, selenazole, furan, thiophene, benzene, naphthalene, phenanthrene, pyridine, pyrimidine, pyrazine or pyridazine.

Assignments (2)
CHANGE OF NAME Recorded Mar 20, 2013
From: NIPPON STEEL CHEMICAL CO., LTD.
To: NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD.
Reel/Frame 030049/0771 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2008
From: MATSUO, SHINJI; HASHIMOTO, HIROMI; ISHII, KAZUO
To: NIPPON STEEL CHEMICAL CO., LTD.
Reel/Frame 020669/0522 →